Should the patent system for new medicines be abolished?

Clin Pharmacol Ther. 2007 Nov;82(5):488-90. doi: 10.1038/sj.clpt.6100393.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomedical Research / legislation & jurisprudence*
  • Commerce / legislation & jurisprudence*
  • Cost-Benefit Analysis
  • Drug Costs / legislation & jurisprudence*
  • Drug Industry / legislation & jurisprudence*
  • Financing, Government
  • Humans
  • Insurance Coverage
  • Legislation, Drug / standards*
  • Legislation, Drug / trends
  • Orphan Drug Production / legislation & jurisprudence
  • Patents as Topic / legislation & jurisprudence*
  • Pharmaceutical Preparations / economics*
  • Public Policy
  • United States

Substances

  • Pharmaceutical Preparations